3 blue chips for your portfolio

Many investors may be looking at the share prices of the banks and wondering where on earth they are going to park their funds as their term deposits mature. Many face putting up very low interest rates, or having to make a decision to invest elsewhere.

With bank share prices looking extremely expensive despite the fully franked dividends, investors are desperately seeking safe, reliable businesses to invest in.

Here’s three companies that might not look cheap now, but could leave the S&P/ASX 200 index (Index:^AXJO) (ASX:XJO) in their dust over the next five to ten years.

CSL Limited (ASX:CSL) is currently trading on a trailing P/E ratio of 24.1, but could see growth of around 20% per annum over the next few years. New products developed from blood plasma to treat a host of diseases may be coming to add to the company’s existing lineup, along with more sales into developing countries could see sales and profits rise. Add in the company’s ongoing share buybacks, and existing shares could be worth multiples of the current price.

Cochlear Limited (ASX:COH) is reportedly facing increased competition from revitalised competitors, as well as Chinese startups. But don’t let that fool you. Cochlear develops premium hearing devices and has more products in the pipeline. When it comes to people’s health, quality is king, and Cochlear is likely to profit from rising awareness of its products globally.

Telstra Corporation (ASX:TLS) may not be able to grow its mobile or broadband business too much further in Australia. It already has dominant positions in both, and Australia’s market is fairly small and growing at a slow rate. But its smaller, unsung divisions such as cloud computing, network applications and data services could see massive growth in the years ahead. Shareholders could see Telstra’s legendary dividend significantly higher in ten years’ time.

Foolish takeaway

While the banks are unlikely to grow significantly from here, without a big increase in credit growth, these three may be better options for those looking for solid, blue chip companies for their portfolio.

Interested in our #1 dividend-paying stock? Discover The Motley Fool’s favourite income idea for 2013-2014 in our brand-new, FREE research report, including a full investment analysis! Simply click here for your FREE copy of “The Motley Fool’s Top Dividend Stock for 2013-2014.”

More reading

Motley Fool writer/analyst Mike King owns shares in CSL, Cochlear and Telstra.

The 5 mining stocks we’re recommending in 2019…

For decades, Australian mining companies have minted money for individual investors like you and me. But if you believe the pundits and talking heads on TV, those days are long gone. Finito! Behind us forever…

We say nothing could be further from the truth. To earn the really massive returns, you’ve got to fish where others aren’t fishing—and the mining sector could be primed for a resurgence. That’s why top Motley Fool analysts just revealed their exciting new research on 5 ASX miners they believe could help you profit in 2019 and beyond…


The best way we see to play the global zinc shortage… Our #1 favourite large-cap miner (hint: it’s not BHP)… one early-stage gold miner we think could hit the motherlode… Plus two more surprising companies you probably haven’t heard of yet!

For free access to our brand-new research, simply click here or the link below. But be warned, this research is available free for a limited time only, and we reserve the right to withdraw it at any time.

Click here for your FREE report!